This trial will compare the effects of topical cysteamine cream with laser treatment in treating melasma. Participants will receive laser treatments and use topical cysteamine cream for 12 weeks.
1 Primary · 0 Secondary · Reporting Duration: 12 Weeks
2 Treatment Groups
Fractional 1927nm Low-Powered Diode Laser combined with Topical Cysteamine
1 of 2
Topical Cysteamine Alone
1 of 2
20 Total Participants · 2 Treatment Groups
Primary Treatment: Fractional 1927nm Low-Powered Diode Laser combined with Topical Cysteamine · No Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 74 · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is there an age limit to eligibility for this medical trial?
"Individuals must be of legal age and no older than 74 years old to take part in the trial, as these parameters were set for inclusion criteria." - Anonymous Online Contributor
Is enrollment for this investigation still open?
"According to the data provided by clinicaltrials.gov, this medical experiment is currently seeking participants. The trial was originally published on October 28th 2022 and recently revised on December 15th 2022." - Anonymous Online Contributor
What is the upper bound of participants taking part in this research endeavor?
"Affirmative. Per the details on clinicaltrials.gov, this medical trial is presently looking for volunteers to take part in it - with its initial posting date being October 28th 2022 and most recent update taking place December 15th 2022. The research requires 20 patients from a single site." - Anonymous Online Contributor
Would I be eligible to join this clinical examination?
"This clinical trial is welcoming 20 volunteers aged 18 to 74 who have melasma. To be eligible for this study, individuals must possess a Skin Type I-VI and understand the Informed Consent form; moreover, they need to commit to all subsequent follow-ups required by the research team." - Anonymous Online Contributor